Cargando…
Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester
Preeclampsia (PE) is a multi-factorial disorder of pregnancy, and it continues to be one of the leading causes of fetal and maternal morbidity and mortality worldwide. Aspirin is universally recommended for high-risk women to reduce preeclampsia risk. The purpose of this review is to summarize the r...
Autores principales: | Tousty, Piotr, Fraszczyk-Tousty, Magda, Dzidek, Sylwia, Jasiak-Jóźwik, Hanna, Michalczyk, Kaja, Kwiatkowska, Ewa, Cymbaluk-Płoska, Aneta, Torbé, Andrzej, Kwiatkowski, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295279/ https://www.ncbi.nlm.nih.gov/pubmed/37371598 http://dx.doi.org/10.3390/biomedicines11061495 |
Ejemplares similares
-
Effectiveness of Different Algorithms and Cut-off Value in Preeclampsia First Trimester Screening
por: Tousty, Piotr, et al.
Publicado: (2022) -
Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension
por: Tousty, Piotr, et al.
Publicado: (2023) -
Adverse Neonatal Outcome of Pregnancies Complicated by Preeclampsia
por: Tousty, Piotr, et al.
Publicado: (2022) -
Birth Weight < 3rd Percentile Prediction Using Additional Biochemical Markers—The Uric Acid Level and Angiogenesis Markers (sFlt-1, PlGF)—An Exploratory Study
por: Bednarek-Jędrzejek, Magdalena, et al.
Publicado: (2022) -
First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction
por: Czuba, Bartosz, et al.
Publicado: (2022)